Vaccine Shortages: An Update

2002 ◽  
Author(s):  
Michelle Meadows
Keyword(s):  
2004 ◽  
Vol 10 (1-2) ◽  
pp. 6-11
Author(s):  
H. Y. M. Ali

Effect of sanctions on hepatitis B vaccine availability and occurrence of viral hepatitis B among Iraqi children was studied. Between June 2000 and June 2001, families of patients attending the Public Health Laboratory, Mosul, for hepatitis B follow-up were screened. Enzyme-linked immunosorbent assay was used to test for HBsAg, HBeAg and anti-HBe. We diagnosed 74 children born 1994-1998 as HBsAg carriers. For 62 of 74 cases, parents had consulted vaccine centres promptly:41 were not vaccinated and 21 had only one vaccine dose. HBeAg marker was positive for 9 [14.5%] and anti-HBe for 50 [80.7%]. Parental reluctance was the reason for non-vaccination for 12. Vaccine shortages during the birth years of cases were documented, even after implementation of United Nations Security Council Resolution 986


2021 ◽  
Vol 9 ◽  
Author(s):  
Hamad Ali ◽  
Barrak Alahmad ◽  
Abdullah A. Al-Shammari ◽  
Abdulmohsen Alterki ◽  
Maha Hammad ◽  
...  

Background: The emergence of new COVID-19 variants of concern coupled with a global inequity in vaccine access and distribution has prompted many public health authorities to circumvent the vaccine shortages by altering vaccination protocols and prioritizing persons at high risk. Individuals with previous COVID-19 infection may not have been prioritized due to existing humoral immunity.Objective: We aimed to study the association between previous COVID-19 infection and antibody levels after COVID-19 vaccination.Methods: A serological analysis to measure SARS-CoV-2 immunoglobulin (Ig)G, IgA, and neutralizing antibodies was performed on individuals who received one or two doses of either BNT162b2 or ChAdOx1 vaccines in Kuwait. A Student t-test was performed and followed by generalized linear regression models adjusted for individual characteristics and comorbidities were fitted to compare the average levels of IgG and neutralizing antibodies between vaccinated individuals with and without previous COVID-19 infection.Results: A total of 1,025 individuals were recruited. The mean levels of IgG, IgA, and neutralizing antibodies were higher in vaccinated subjects with previous COVID-19 infections than in those without previous infection. Regression analysis showed a steeper slope of decline for IgG and neutralizing antibodies in vaccinated individuals without previous COVID-19 infection compared to those with previous COVID-19 infection.Conclusion: Previous COVID-19 infection appeared to elicit robust and sustained levels of SARS-CoV-2 antibodies in vaccinated individuals. Given the inconsistent supply of COVID-19 vaccines in many countries due to inequities in global distribution, our results suggest that even greater efforts should be made to vaccinate more people, especially individuals without previous COVID-19 infection.


Science ◽  
1985 ◽  
Vol 228 (4697) ◽  
pp. 308-309
Author(s):  
M. SUN
Keyword(s):  

2010 ◽  
Vol 31 (10) ◽  
pp. 987-995 ◽  
Author(s):  
Thomas R. Talbot ◽  
Hilary Babcock ◽  
Arthur L. Caplan ◽  
Deborah Cotton ◽  
Lisa L. Maragakis ◽  
...  

Executive SummaryThis document serves as an update and companion piece to the 2005 Society for Healthcare Epidemiology of America (SHEA) Position Paper entitled “Influenza Vaccination of Healthcare Workers and Vaccine Allocation for Healthcare Workers During Vaccine Shortages.” In large part, the discussion about the rationale for influenza vaccination of healthcare personnel (HCP), the strategies designed to improve influenza vaccination rates in this population, and the recommendations made in the 2005 paper still stand. This position paper notes new evidence released since publication of the 2005 paper and strengthens SHEA's position on the importance of influenza vaccination of HCP. This document does not discuss vaccine allocation during times of vaccine shortage, because the 2005 SHEA Position Paper still serves as the Society's official statement on that issue.


PEDIATRICS ◽  
2007 ◽  
Vol 120 (5) ◽  
pp. e1165-e1173 ◽  
Author(s):  
P. J. Smith ◽  
J. P. Nuorti ◽  
J. A. Singleton ◽  
Z. Zhao ◽  
K. M. Wolter

2004 ◽  
Vol 4 (6) ◽  
pp. 989-992 ◽  
Author(s):  
Maria Lattanzi ◽  
Rino Rappuoli
Keyword(s):  

PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0248053
Author(s):  
Dean Matter ◽  
Linke Potgieter

The tumultuous inception of an epidemic is usually accompanied by difficulty in determining how to respond best. In developing nations, this can be compounded by logistical challenges, such as vaccine shortages and poor road infrastructure. To provide guidance towards improved epidemic response, various resource allocation models, in conjunction with a network-based SEIRVD epidemic model, are proposed in this article. Further, the feasibility of using drones for vaccine delivery is evaluated, and assorted relevant parameters are discussed. For the sake of generality, these results are presented for multiple network structures, representing interconnected populations—upon which repeated epidemic simulations are performed. The resource allocation models formulated maximise expected prevented exposures on each day of a simulated epidemic, by allocating response teams and vaccine deliveries according to the solutions of two respective integer programming problems—thereby influencing the simulated epidemic through the SEIRVD model. These models, when compared with a range of alternative resource allocation strategies, were found to reduce both the number of cases per epidemic, and the number of vaccines required. Consequently, the recommendation is made that such models be used as decision support tools in epidemic response. In the absence thereof, prioritizing locations for vaccinations according to susceptible population, rather than total population or number of infections, is most effective for the majority of network types. In other results, fixed-wing drones are demonstrated to be a viable delivery method for vaccines in the context of an epidemic, if sufficient drones can be promptly procured; the detrimental effect of intervention delay was discovered to be significant. In addition, the importance of well-documented routine vaccination activities is highlighted, due to the benefits of increased pre-epidemic immunity rates, and targeted vaccination.


Author(s):  
Oumy Baala Thiongane

Based on an analysis of the Meningitis Vaccine Project (MVP), a public-private partnership (PPP) set up to introduce the MenAfriVac® vaccine in African countries, this article examines the failures of an accelerated disease control programme that targeted a highly infectious disease. I argue that the integration of MenAfriVac® into the World Health Organization’s (WHO) Expanded Programme on Immunisation had the effect of reinforcing inequalities in access, in particular during epidemic emergencies. I will also show how vaccine shortages during an outbreak in Niger led to political tensions and to the emergence of a parallel and unregulated ‘black market’ of vaccines.


Sign in / Sign up

Export Citation Format

Share Document